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 Summary
	 Background:  The	objective	of	our	study	was	to	compare	histological	and	radiological	images	of	the	hamartomas	
(H)	 localized	 in	 lungs.	The	analysis	consisted	of	54	cases,	which	were	diagnosed	and	operated	on	
in	 Specialistic	Hospital	 of	Tuberculosis	 and	Pulmonary	Diseases	 in	Rzeszow	 in	 years	 1999-2005.	
Average	age	of	patients,	mostly	men,	was	55	years.	H	was	diagnosed	accidentally	in	75%	of	cases,	
and	was	not	related	with	other	diseases.	Histologically,	cartilaginous	or	fibro-cartilaginous	tissues	
dominated	in	H	structures;	H	with	adipose	tissue	component	appeared	rarely.	Diameter	of	H	was	
less	 than	3	cm	 in	most	of	 the	cases.	All	H	were	 located	peripherally	 in	 the	chest	and	showed	no	
preferences	 to	 the	 localization.	 Computed	Tomography	demonstrated	 calcifications	 in	 30%	of	H.	
As	 for	 etiology,	 clinical	 and	 histological	 aspects	 of	 the	H	 and	 also	 differential	 diagnosis	 of	 the	
radiological	features	were	presented.
 Key words:  Pulmonary hamartoma • Chest X-ray • Computed Tomography
 PDF file: http://www.polradiol.com/fulltxt.php?ICID=468398
Otrzymano: 2006.03.14 
Zaakceptowano:2006.06.20
Sygnatura:Pol J Radiol, 2007; 72(1): 36-43
Background
Hamartoma	 (H)	 is	 a	 lesion	 composed	 of	 mature	 tissues	
(muscular,	 fibrous,	 cartilaginous,	 osseous	 and	 adipose	 tis-
sues)	which	do	not	form	organized	structures	[1]	(fig.	1,	2).
They	arise	 from	multipotential	mesenchyma	which	 shows	
the	 ability	 to	 differentiate	 into	 mature	 tissues.	 Singular	
cases	of	transformations	into	malignant	tumors	have	been	
described	[2,	3,	4].	It	 is	now	believed	that	hamartomas	are	
not	congenital	lesions	and	they	occur	in	individual	lives	as	
a	result	of	unknown	pathogenetic	factors	[5].	In	some	cases	
familial	tendency	for	H	incidence	was	observed,	especially	
in	 lungs.	 Inflammations	were	 considered	 as	 the	 initiative	
factors	 for	 proliferation	 in	 these	 cases,	 although	 recently	
a	 relation	between	 gene	mutations	 and	H	occurrence	has	
been	 proved.	 Some	 claim	 that	 smoking	 can	 influence	 the	
	development	 of	 H	 [6,	7].	 However,	 H	 can	 grow	 in	 every	
kind	of	 organ.	The	occurrence	 of	 one	 tumor	or	multifocal	
infiltration	of	 several	organs	 is	 the	base	of	varied	clinico-
morphological	pattern.	
H	located	in	the	lungs	are	the	most	common	benign	lesions	
and	constitute	about	30%	of	all	benign	pulmonary	 tumors	
[8,	9].	 Half	 of	 them	 take	 the	 form	 of	 solitary	 peripheral	
	nodules	of	slow	growth	(solitary	pulmonary	nodule	–	SPN)	
[8].	The	incidence	in	population	is	estimated	for	0.25%	[10],	
two	to	four	times	more	frequent	in	men	than	women	[11].	
The	 age	 of	 patients	 varies	 from	30	 to	 70	 years,	 the	 peak	
occurrence	being	 in	 the	 6th	 decade	 of	 life	 [12,	13]	 but	 the	
important	thing	is	–	they	do	not	occur	in	neonates,	infants	
and	small	children.	
In	most	 cases	 they	 grow	as	 solitary	 tumors.	Hamartomas	
are	 located	 in	 peripheral	 regions	 of	 lung	 as	well	 as	 inside	
the	 bronchial	 tubes	 and	 show	no	 significant	 tendency	 for	
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occupying	certain	lobes	or	a	lung	[11,	12].	The	average	size	
varies	from	1.5	to	3	cm	[11,	12]	and	does	not	depend	on	ana-
tomical	 localization	but	 shows	certain	 level	of	dependency	
on	 advancing	 age	 of	 a	 patient	 [12].	 Endobronchial	 lesions	
constitute	10–20%	of	pulmonary	hamartomas	[10,	13,	14].
In	literature	it	is	emphasized	that	even	the	biggest	nodules	
located	 in	 the	 pulmonary	 parenchyma	 give	 no	 clinical	
symptoms	 [11,	 14,	 15]	 while	 those	 in	 the	 bronchi	 often	
cause	 cough,	 hemoptysis,	 fever,	 respiratory	disfunction	 or	
pneumonia	 [9,	10,	16,	17].	The	course	of	H	 is	mild	but	 the	
treatment	of	choice	is	surgical	resection	of	the	lesion	[6,	11,	
12,	14,	15].	This	is	usually	because	in	many	centers	the	pos-
sibility	of	malignant	development	(peripheral	carcinoma)	or	
focal	 inflammatory	 lesion	 (e.g.	 tuberculoma)	 is	 taken	 into	
consideration	 in	 cases	of	 indefinite	diagnosis	of	 lesions.	 If	
the	location	is	endobronchial,	clinical	symptoms	(hemopty-
sis,	atelectasis,	 inflammation	of	segment	of	a	 lung)	depen-
dent	 on	 the	 level	 of	 bronchial	 occlusion,	 become	 a	 direct	
indication	for	surgical	treatment.	
No	matter	if	the	hamartomas	are	located	in	peripheral	pul-
monary	parenchyma	or	inside	the	bronchi,	they	show	minor	
structural	 differences	 [18].	 Peripheral	 H	 are	 represented	
by	multilobular	 solid	 tumors	 of	 oval	 or	 round	 shape	with	
smooth	or	irregular	contours	[19],	embedded	in	pulmonary	
parenchyma.	 Their	 consistency	 depends	 on	 the	 propor-
tion	of	tissue	elements.	On	the	contrary,	the	endobronchial	
hamartomas	take	the	form	of	polyp	growing	into	the	lumen	
of	bronchi	[18,	19]	and	occlude	it	to	some	extend.	
Hamartomas	 are	 usually	 built	 from	mature	 cartilaginous	
tissue,	which	 forms	 clusters	 surrounded	by	variable	 cell-
rich	fibrous	and	myxomatous	tissue	mixed	with	focuses	of	
adipose	tissue	and	fibers	of	smooth	muscles	[10].	Focuses	of	
calcification	and	osteoplasia	or	proliferation	of	thin-walled	
blood	vessels	are	less	often.	The	stroma	of	tumor	is	covered	
with	 bronchial	 cylindrical	 epithelium	 which	 can	 form	
indentations	or	fissures.	Some	Hs	are	only	built	of	 fibrous	
and	muscle	tissues	 [20].	In	others	an	immature	mesenchy-
ma	forming	polycyclic	confluent	nodules	is	observed.	They	
might	 grow	or	undergo	 cystic	 degeneration	 in	 subsequent	
observations	 (the	 so-called	mesenchymal	 cystic	 hamarto-
mas)	 [21,	 22,	 23].	 Structures	 similar	 to	 placental	 villi	 are	
identified	 in	 some	 hamartomas	 [24].	 In	 such	 cases	 they	
are	peculiar	 villuslike	papillary	projections,	 the	 stroma	of	
which	is	built	of	myxolipomatous	tissue	covered	with	epi-
thelium.	Such	structures	are	usually	observed	in	emphyse-
matously	altered	pulmonary	parenchyma.	Focuses	of	macro-
phages	containing	brown	pigment	can	often	be	found	in	the	
lumen	of	pulmonary	alveoli	near	the	hamartoma.	
Formation	of	multiple	hamartomas	occupying	central	ner-
vous	 system,	 kidneys,	 skin,	 lungs	 and	heart	 is	 one	 of	 the	
morphological	 exponents	 of	 tuberous	 sclerosis	 complex	
(TSC).	 In	 population	 it	 occurs	 with	 frequency	 of	 1:6000	
[25]	and	is	 inherited	autosomally	as	a	dominant	trait.	It	 is	
caused	 by	TSC	 1	 and	TSC	 2	 gene	mutations.	 TSC	 related	
hamartomas	 rarely	 become	 malignant.	 The	 exception	 is	
renal-v-cell	 carcinoma,	which	 develops	 from	 renal	 ham-
artoma	 [26].	 The	 renal	H	 in	 form	of	 angiolipoma	 is	 often	
	associated	with	tuberous	sclerosis	and	as	such	is	known	as	
Bourneville’s	syndrome	[27].	
On	the	other	hand,	multiple	Hamartomas	ocurrence	can	be	
a	part	of	Carney’s	triad	–	a	rare	syndrome	of	unknown	eti-
ology	which	occurs	most	often	in	young	women.	The	triad	
includes	 pulmonary	 chondroma,	 gastrointestinal	 stromal	
tumor	(GIST)	and	extra-adrenal	phaeochromocytoma	[28].	
Due	to	the	fact	that	hamartomas	are	asymptomatic	in	most	
cases,	they	are	usually	diagnosed	accidentally	during	plain	
radiological	 examinations	 of	 the	 thorax	 [6].	 Radiological	
image	usually	 shows	 oval	 or	 round	 shadow	with	 smooth	
contours,	sometimes	with	calcification	focuses	[9,	29].
The	plain	radiological	examination	of	the	chest	often	reveals	
a	round	shadow	in	a	lung.	The	exam	is	most	often	performed	
in	 typical	 –	 anteroposterior	 and	 lateral	 –	 projections.	Other	
projections	(oblique)	or	thoracic	scopy	can	be	used	for	visual-
izing	indistinct	or	doubtful	lesions.	Radiological	evaluation	is	
easier	when	the	location	of	nodule	is	far	from	the	diaphragm,	
mediastinum	or	thoracic	wall,	and	the	easiest	 in	 intercostal	
space.	The	RTG	of	 the	chest	usually	reveals	H	as	a	solitary,	
well	circumscribed,	round	or	(rarely)	oval	nodule	with	diam-
eter	 of	 4	 cm	 (median	2	 cm),	 localized	peripherally	 in	 lower	
pulmonary	lobes	(fig.	3).	Calcifications	often	placed	centrally,	
with	 characteristic	 arrangement	 resembling	 popped	 corn	
(“popcorn	sign”)	are	stated	in	10–15%	of	H	cases	[32,	33].	
Figure 2.	 	Hamartoma	compound	with	fibrous	and	muscular	tissue.Figure 1.	 	Cartilaginous	structure	of	the	hamartoma	with	fatty	tissue	
and	calcifications	components.
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Computed	 tomography	with	contrast	agent	administration	
and	 densitometry	 enables	 a	 more	 precise	 delineation	 of	
morphological	features	of	a	fortuitously	discovered	nodule.	
Typical	representation	of	H	in	CT	exam	is	a	solitary	nodule	
of	round	or	oval	shape	and	low	density	(especially	if	it	con-
tains	 larger	 amount	 of	 adipose	 tissue),	with	 sharp	 edges,	
localized	peripherally	 in	 lower	 lobes,	well	–	circumscribed	
and	containing	single	or	popcorn-like	calcifications	 (fig.	4)	
[30,	31,	32].
Materials and methods
The	study	comprised	54	patients	 including	33	men	and	21	
women	aged	24	–	74.	Average	age	of	both,	men	and	women,	
was	 55	 years.	 All	 patients	were	 diagnosed	 and	 operated	
on	at	 Specialistic	Hospital	 of	Tuberculosis	 and	Pulmonary	
Diseases	in	Rzeszow	in	years	1999–2005.	RTG	of	lungs	was	
always	 performed	 in	 anteroposterior	 and	 lateral	 projec-
tion,	and	18	patients	underwent	additional	CT	exam	with	
the	use	of	typical	protocol,	only	in	a	few	cases	with	HRCT	
protocol.	8	patients	underwent	bronchoscopy,	while	bron-
chial	contents	were	collected	from	other	3	for	cythological	
	examination.	Bronchial	specimens	were	not	examined.	
The	 preoperative	 diagnostics	 did	 not	 include	 thin-needle	
aspiration	biopsy	because	of	small	dimensions	of	 the	nod-
ule	or	lack	of	patient’s	agreement.	In	no	case	was	the	defi-
nite	diagnosis	based	on	clinical,	 imaging	or	cytomorpholo-
gical	examinations	made	before	the	operation.	All	patients	
underwent	 thoracotomy	with	 tumor	 resection.	All	 lesions	
were	 examined	 intra-operatively.	The	 surgical	 procedures	
of	H	 resection	 constituted	 5.8%	of	 all	 thoracotomies	 con-
ducted	for	neoplastic	reasons	at	the	Department	of	Thoracic	
Surgery.	 In	 51	 cases	 sparing	 operations	were	 performed	
(simple	 resection	 of	 the	nodule,	marginal	 or	wedge	 resec-
tion).	 In	 3	 cases	 the	decision	 of	 pulmonary	 lobe	 resection	
was	made	due	to	big	dimensions	of	 the	 lesion.	The	opera-
tions	 were	 carried	 out	 in	 accordance	 with	 conventional	
standards.	They	proceeded	without	complications.	
Following	check-up	examinations	after	7,	14,	21	days	and	
1,	2,	3,	6	and	12	months	revealed	no	permanent	complica-
tions,	no	 local	 recurrences,	no	signs	of	malignant	process.	
The	operative	material	was	assessed	by	means	of	histologi-
cal	and	immunochemical	examinations.
Results
Patients	were	divided	 into	 three	 age	 groups	 (table	 1).	The	
dominating	 group	 comprised	 patients	 aged	 40–60	 (62%).	
61%	 of	 patients	were	male,	 but	 this	 ratio	was	 higher	 in	
groups	 aged	 40–60	 and	 over	 60,	while	 in	 the	 group	 aged	
20–40	the	proportion	of	men	and	women	was	equal	(50%).	
However,	it	was	a	small	group	of	patients	(7.5%).
In	 72%	of	 patients	no	 respiratory	 troubles	were	 stated	 at	
the	 time	of	H-type	 lesions	detection	and	the	RTG	of	 lungs	
was	performed	as	a	periodic	examination	or	 in	relation	to	
other	 diseases.	 Other	 patients	 complained	 of	 cough	 (9%),	
dyspnea	 (7.5%),	 chest	 pain	 accompanied	 by	 weakness	
(4.5%)	and	in	single	cases	–	of	subfebrile	body	temperature	
Figure 3.	 	Typical	X-ray	image	of	the	pulmonary	Hamartoma.
A B
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or	hemoptysis.	 In	one	case	of	endobronchial	H	the	patient	
suffered	 from	 dyspnea	 and	 cough.	 Among	 the	 coexisting	
	diseases	 the	 most	 common	 were	 arterial	 hypertension	
(18.5%),	 less	 often	 –	 chronic	 ulcer	 disease	 and	 nodular	
	goiter	 (5.5%).	30	patients	out	of	54	answered	 the	question	
concerning	smoking	cigarettes	–	the	number	of	nonsmokers	
(53%)	almost	equaled	the	smokers	(47%).	
All	 patients	 underwent	 radiological	 examination	 of	 the	
thorax	which	 revealed	 lesions	 in	 form	of	 round	 or	 oval	
solitary	 shadows,	 with	 smooth	 contours	 and	 well-cir-
cumscribed	 from	 the	 surrounding	 tissues.	 In	 all	 cases	
the	 localization	was	 peripheral,	 regular,	without	 predi-
lections	to	a	certain	segment	of	lung	(table	2).	
The	size	of	 focuses	varied	from	6	mm	to	7	cm,	but	most	
of	the	lesions	did	not	exceed	3	cm	and	only	in	6	patients	
(10.1%)	 the	 nodules	 were	 equal	 or	 bigger	 than	 3	 cm.	
There	is	a	slender	correlation	between	the	advancing	age	
of	patients	and	size	of	the	nodule.	Small	nodules	up	to	1	
cm	were	more	frequent	in	women	(table	3).	It	was	noted	
that	in	the	group	of	H	containing	adipose	tissue	the	diam-
eter	 of	 nodules	 did	not	 exceed	1	 cm,	while	 in	 the	 group	
of	nodules	over	3	cm	mixed	or	cartilaginous	 forms	were	
dominant.	During	RTG	 examinations	 calcifications	were	
found	in	20%	of	cases	but	in	patients	who	underwent	the	
CT	the	percentage	grew	to	30%.	The	calcifications	 found	
Figure 4.	 	Different	morphology	of	hamartoma	(adipose	tissue,	
calcificationes)	visible	in	CT	examination.
Table 3.  Relations	beetwen	dimensions	of	the	Ph	and	age	or	sex	groups.
Age	groups dimensions
total %	to	1	cm/manpower		of	the	group	Sex Up	to	1	cm 1–3	cm over	3	cm
Up	to	40	y. 1 3 0 4 25%
41-60	y. 6 23 5 34 17,65%
over	60	y. 3 12 1 16 18,75%
Total 10 38 6 54 18,51%
women 7 12 2 21 33,33%
men 3 26 4 33 9,09%
Total 10 38 6 54 18,51%
Table 1.  Division	of	the	patients	with	Ph	for	age	and	sex	groups.
Age	groups
Sex
Total %
female male
Up	to	40	y. 2 2 4 7,41
41-60	y. 13 21 34 62,96
over	60	y. 6 10 16 29,63
Total 21 33 54 100,00
Table 2.  Localisation	of	Ph	in	lobes	and	lungs.
Localization Upper	lobe Lower	lobe Central	lobe Total
Right	lung 10 13 4 27
left	lung 14 13 0 27
Total 24 26 4 54
A B
40
Pol J Radiol, 2007; 72(1): 36-43Original Article
at	CT	were	usually	 located	peripherally,	 they	were	 soli-
tary,	regular,	point	or	oval	and	if	they	were	multiple	they	
showed	tendency	for	cumulating.	However,	 the	so-called	
“popcorn	sign”	was	extremely	rare.	
None	of	the	nodules	showed	focuses	of	decomposition	or	air	
cavities.	The	level	of	contrast	enhancement	of	focuses	was	
moderate	 and	varied	 from	0–15	HU	and	depended	 largely	
on	 histological	 structure	 of	 the	 nodule.	 In	 cases	 when	
lesions	 contained	 adipose	 tissue	 (about	 15%)	 their	 density	
was	 low	 (-20	 to	+	5	HU)	 and	 enhancement	poor	 or	none.	
The	density	of	cartilaginous	or	fibrous	lesions	observed	on	
native	scans	varied	from	20	to	40	HU	but	they	showed	bet-
ter	enhancement	in	some	cases	(up	to	55	HU).	
As	 for	histology,	 the	nodules	 contained	different	 propor-
tions	of	cartilaginous,	fibrous	and	adipose	tissues	(table	4).	
Over	half	of	 the	nodules	 (52%)	were	made	of	 exclusively	
cartilaginous	 tissue,	while	 87%	 contained	 cartilaginous	
tissue	in	association	with	other	tissues.	Fibrous	tissue	was	
the	only	building	material	in	7.5%	of	lesions,	but	occurred	
in	 48%	of	mixed	 forms.	Adipose	 tissue	 appeared	 only	 in	
mixed	 forms	 –	 that	 is	 in	 15%	of	 nodules.	 In	women	we	
observed	higher	 incidence	of	H	with	clear	 fibrous	 struc-
ture	 (75%)	and	domination	of	nodules	containing	adipose	
tissue	 (75%).	 In	men,	 on	 the	 other	hand,	 nodules	 of	 car-
tilaginous	 structure	were	 twice	 as	 frequent	 (59%)	 as	 in	
women	(28%).	Mixed	forms	occurred	equally	often	in	men	
and	women.	
In	one	case	(1.8%)	H	grew	endobronchially.	The	nodule	with	
dimensions	of	1.5	x	1.5	x	2.5	cm,	made	of	the	fibrous	and	
adipose	 tissues	was	 located	 in	 the	 lower	 lobe	 of	 left	 lung	
(fig.	5).
8	 patients	 underwent	 preoperative	 bronchoscopy	 which	
showed	traces	of	diffuse	inflammatory	lesions	of	bronchial	
mucosa.
All	patients	were	operated	on	with	the	use	of	thoracotomy	
and	 sparing	 surgeries	 based	 on	 enucleation	 of	 nodule	 or	
wedge	resection	of	pulmonary	parenchyma.
Discussion
Radiological	 images	 enable	H	 diagnosis	 of	 high	 accuracy	
provided	 that	 the	nodule	 is	 round	with	 smooth	 contours,	
smaller	 than	3	 cm,	 shows	presence	of	 “popcorn”	 calcifica-
tions	(cartilaginous	calcifications)	and	is	well-circumscribed	
from	 the	 surrounding	 tissues.	 Differentiating	 diagnosis	
includes	both	 the	benign	 and	malignant	 lesions.	Although	
Table 4.  Tissue	compounds	of	Ph	in	correlations	with	dimensions	of	the	Ph	and	sex	of	patients.
HP	results
Sex
Total
Dimensions
Total HP	%	of	a	group
F M Up	to	1	cm 1	-	3	cm over	3	cm
C 7 21 28 4 22 2 28 51,85
F 3 1 4 2 1 1 4 7,41
F-C 5 9 14 2 11 1 14 25,93
F-C-A 3 2 5 0 3 2 5 9,26
F-A 3 0 3 2 1 0 3 5,55
Total 21 33 54 10 38 6 54 100
Compounds:	C	–	cartilaginous	tissue,	F	–	fibrous	tissue,	A	–	adipose	tissue
Figure 5.	 	Endobronchial	hamartoma	before	(on	the	left)	and	after	operation	–	bronchiectases	are	visible	on	the	left	lower	lobe.
A
B
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the	 size	 of	H	usually	 does	not	 exceed	3	 cm,	half	 (50%)	 of	
	solitary	nodules	 sized	 2–3	 cm	 located	 peripherally	 in	 the	
lung	have	malignant	 characteristics.	Round	or	 oval	 shape	
and	 well	 circumscription	 in	 most	 cases	 indicate	 benign	
lesions,	while	 dim	contours,	 spiculations,	 satellite	 focuses	
suggest	malignant	infiltration.	
Although	solitary	metastases	from	extra-pulmonary	focuses	
often	 show	 similar	 peripheral	 location	 and	 structure,	
the	multiple	 forms	 of	H	 are	 also	 observed.	 Calcifications	
do	not	determine	 the	diagnosis	of	H	as	 the	RTG	examina-
tion	 shows	 them	 only	 in	 20%	 of	 cases	 and	 CT	 –	 in	 30%.	
Calcifications	are	also	found	 in	tuberculomas	but	they	are	
usually	 scattered	 or	 focal	 –	 in	 form	of	 “central	 nucleus”.	
Eccentric	calcifications	are	typical	for	10%	of	primary	pul-
monary	carcinomas	and	frequent	in	carcinoids,	but	diffused	
in	metastases	of	osteosarcoma	[8,	30,	34].	Focuses	of	osse-
ous	metaplasia	occur	in	some	malignant	tumors.	Cavernous	
space	usually	indicates	necrosis	and	dissolution	in	a	malig-
nant	neoplasm,	but	it	is	also	typical	for	pulmonary	abscess	
and	frequent	in	tuberculoma.	Only	a	rare	type	of	H,	the	so-
called	mesenchymal	 cystic	 hamartoma,	 can	have	 cavern-
ous	structure,	clearly	visible	in	RTG	examination.	Doubtful	
lesions	in	RTG	require	further	diagnostics	(table	5).
Computed	 tomography	 (CT)	 is	 a	more	 sensitive	 examina-
tion	than	RTG	of	lungs.	The	usefulness	of	CT	in	evaluation	
of	 solitary	 pulmonary	nodules	 detected	 fortuitously	with	
RTG	 lies	 in	stating	whether	 the	 lesion	 is	a	nodule	or	arti-
fact.	 In	 case	 of	 confirmation	 it	 enables	 precise	 definition	
of	its	shape,	size,	circumscription	and	presence	of	satellite	
	focuses	 (fig.	 6,	 7).	 CT	 is	useful	 for	monitoring	 the	 lesion’s	
growth	 dynamics	 in	 control	 examinations	 as	well	 as	 for	
estimation	 of	 duplication	 time,	which	 is	 long	 for	 benign	
tumors	 (including	 H)	 and	 amounts	 for	 at	 least	 200	 days	
and	100	days	 in	case	of	malignant	 lesions	 [8,	30,	34].	 It	 is	
possible	to	measure	the	density	after	 intravenous	contrast	
administration	during	 the	 examination,	 and	 then	 to	 com-
pare	 it	with	 a	 reference	model.	 CT	 is	useful	 for	 detecting	
the	calcifications	within	the	H,	allowing	its	precise	appear-
ance	and	size	description.	Focuses	of	density	over	100	HU,	
visible	on	native	 scans	and	qualified	as	calcifications,	 can	
be	invisible	on	RTG	images.	In	general,	CT	visualizes	typi-
cal	calcifications	in	25%	of	hamartomas.	
Figure 6.	 	Comparison	of	the	X-ray	and	CT	images	of	the	pulmonary	hamartoma	–	difficulty	of	identification	of	the	lesion	on	chest	X-ray	is	visible.
A B
Table 5. Differentiations	of	the	Ph	in	dependencies	from	radiological	cryteria.
Radiological	criterion Hamartoma Other	benign	lesion Malignant	neoplasm
size Up	to	3	cm Up	to	3	cm 50%	up	to	2	cm,	Most	over	3	cm
structure Oval	or	round	shape	well-
circumscribed	smooth	contours
Oval	or	round	shape	well-
circumscribed	smooth	contours
Not	well-circumscribed,	dim	contours,
metastases	often	well	circumscribed
calcifications in	20-30%	punctual,	oval,		
rarely	in	form	of	
the	so-called	pop	corn	sign
diffuse	or	„central	nuclei”	
(tuberculoma)
excentric	in	10%	of	primary	pulmonary	
carcinomas	(carcinoid),
diffuse	in	metastases	of	osteosarcoma,	
osseous	metaplasia	in	malignant	tumors
cavernous	space rarely	–	the	so-called		
mesenchymal	cystic	hamartoma
Pulmonary	absces,		
tuberculoma
frequent
adipose	tissue in	15%	of	H lipoma,	lipoid	pneumonia none
satellite	nodules none granuloma bronchiogenic	carcinoma
contrast	enhancement low rarely strong
growth none	or	duplication	time	–	2	years none	or	duplication	time	–	2	years duplication	time	–	100	days
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Owing	 to	density	measurements	detection	of	adipose	 tissue	
is	possible	in	30	%	of	H	cases	as	this	type	of	tissue	presents	
a	characteristically	low	density	(around	-70	to	-110	HU).	This	
type	of	tissue	is	present	in	benign	lesions	(e.g.	lipoma)	which	
occur	in	lungs	far	less	frequently	than	H	but	is	never	found	
in	malignant	neoplasms.	Analysis	 of	CT	 image	 followed	by	
density	 measuring	 after	 contrast	 administration	 allows	
defining	the	character	of	a	solitary	nodule	and	answering	the	
question,	whether	the	tumor	is	benign	or	malignant.	Benign	
lesion	 is	characterized	by	 low	uptake	of	contrast	agent	and	
low	density	(<	15	HU).	If	the	density	is	over	20	HU	the	risk	
of	malignant	lesion	increases.	In	such	case,	the	CT	examina-
tion	can	help	define	the	level	of	its	advancement.	Computed	
tomography	 (especially	 spiral	 and	 multi-slice	 CT)	 is	 the	
method	of	choice	in	evaluation	and	monitoring	the	peripheral	
pulmonary	nodules	 as	 it	 gives	 a	precise	 image	of	 all	 struc-
tures	 of	 pulmonary	parenchyma,	has	high	 linear	 resolution	
and	short	time	duration,	owing	to	which	the	artifacts	can	be	
evaded	eliminated	[30,	31,	32].
The	 use	 of	 Positron	 Emission	 Tomography	 (PET)	 with	
fluoro-deoxy-glucose	 (FDG)	 for	 differentiating	 benign	 and	
malignant	 lesions	 is	still	under	research.	High	metabolism	
accompanied	by	higher	FDG	consumption	indicates	a	malig-
nancy	of	the	nodule	[33].	The	unquestionable	advantage	of	
the	method	is	its	noninvasiveness	and	rare	presentation	of	
false	negative	results.	Yet,	it	is	an	expensive	method	of	low	
accessibility	and	bares	a	risk	of	10–15%	of	 falsely	positive	
results.	The	minimal	size	of	nodule	necessary	for	evaluating	
its	metabolism	is	1	cm.
In	 order	 to	 numerous	 limitations	 arising	 from	 the	 struc-
ture	 of	 pulmonary	parenchyma	as	well	 as	 from	 technical	
aspects	the	magnetic	resonance	is	not	widely	applicable	in	
diagnostics	 of	 small	 peripheral	 pulmonary	nodules	which	
are	not	connected	to	mediastinal	structures	and/or	thoracic	
wall.	Among	 the	significant	 limitations	of	 the	MR	method	
we	should	mention:
–		lack	of	MR	signal	from	pulmonary	air-tissue	which	is	the	
basis	of	 image	construction	and	therefore	small	 lesions	
surrounded	 with	 pulmonary	 parenchyma	 are	 hardly	
visible
–		artifacts	which	occur	during	patient’s	 respiratory	move-
ments	and	the	movements	of	mediastinal	organs
–		low	linear	resolution	which	does	not	allow	a	precise	defi-
nition	of	morphology	of	small	focal	lesions
–		long	 duration	 of	 the	 procedure	which	 results	 from	 the	
necessity	 to	 use	 gating	 of	 respiratory	 and	 heart	move-
ments
The	 indications	 for	 thoracic	MR	 in	 the	 first	 place	 include	
the	evaluation	of	pathologic	changes	within	the	structures	
of	heart	and	large	mediastinal	vessels.	In	case	of	prolifera-
tive	processes	the	MR	enables	a	more	precise	(than	the	CT)	
evaluation	of	 infiltration	 to	 the	 thoracic	wall,	mediastinal	
organs,	heart,	large	vascular	trunks	and	presence	of	metas-
tases	in	mediastinal	lymphatic	glands	[34].	
Although	rarely	performed	due	to	small	dimensions	of	H	
and	deep	 localization,	 the	 thin-needle	 biopsy	monitored	
by	RTG,	CT	or	USG	is	the	examination	of	high	specificity,	
especially	 if	 the	 lesion	 is	 situated	 near	 the	 surface	 of	
lung	 or	 subpleurally.	 In	most	 cases	 it	 provides	 diagnos-
tic	 cytological	material.	 Confrontation	 of	 its	 image	with	
clinical	 and	 radiological	 results,	 in	 some	 cases,	 followed	
by	 immunohistochemical	 identification	 of	 fibromyxoma-
tous	structures	by	means	of	S-100	protein	makes	enables	
correct	 diagnosis.	Unfortunately,	 the	 diameter	 of	 nodule	
smaller	 than	2	 cm	and	 its	 stiff	 consistency	 connected	 to	
cartilaginous	and	osseous	tissues	constitute	a	serious	dif-
ficulty	 in	 obtaining	 the	 representative	material	 [35,	 36,	
37,	38,	39,	40].
Conclusions
1.		Pulmonary	hamartomas	is	a	lesion	most	often	found	for-
tuitously	in	patients	aged	over	40	years,	a	bit	more	often	
in	men.
2.		Histologically,	they	are	mainly	build	of	cartilaginous	tis-
sue	(50%	of	nodules	contain	no	other	tissue	component),	
while	mixed	forms	contain	fibrous	tissue	–	40%	and	adi-
pose	tissue	–	15%.	
3.		Hamartomas	occur	in	the	peripheral	part	of	 lungs,	with	
no	 predilections	 to	 certain	 areas	 in	 lungs	 and	 the	 size	
of	 lesion	at	the	time	of	diagnosis	usually	 (74%)	does	not	
exceed	2	cm.
4.		CT	examinations	reveal	calcifications	in	30	%	of	lesions,	
and	in	15	%	of	cases	–	presence	of	adipose	tissue.	
5.		Pulmonary	hamartoma	has	morphologic	 features	which	
enable	its	detection	in	RTG	or	CT,	especially	when	it	con-
tains	adipose	tissue	or	typical	calcifications.
Figure 7.	 	Pulmonary	hamartoma	on	the	chest	X-ray	in	difficult	to	
diagnose	location.
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